Advertisement

Dermatomyositis

  • Tor Shwayder
  • Samantha L. Schneider
  • Devika Icecreamwala
  • Marla N. Jahnke
Chapter
  • 212 Downloads

Abstract

Dermatomyositis (DM) consists of both cutaneous and musculoskeletal manifestations. The incidence is higher in women than in men. DM is thought to result from an immune-mediated process [2].

References

  1. 1.
    Tomono N, Mori M, Nakajima S, et al. HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis. J Rheumatol. 2004;31(9):1847–50.PubMedGoogle Scholar
  2. 2.
    Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology. 2009;48(6):607–12.CrossRefGoogle Scholar
  3. 3.
    Batthish M, Feldman BM. Juvenile dermatomyositis. Curr Rheumatol Rep. 2011;13(3):216–24.CrossRefGoogle Scholar
  4. 4.
    Timpane S, Brandling-Bennett H, Kristjansson AK. Autoimmune collagen vascular diseases: kids are not just little people. Clin Dermatol. 2016;34(6):678–89.CrossRefGoogle Scholar
  5. 5.
    Papadopoulou C, Wedderburn LR. Treatment of juvenile dermatomyositis: an update. Paediatr Drugs. 2017;19:423–34.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Tor Shwayder
    • 1
  • Samantha L. Schneider
    • 2
  • Devika Icecreamwala
    • 3
  • Marla N. Jahnke
    • 2
  1. 1.Pediatric DermatologyHenry Ford HospitalDetroitUSA
  2. 2.Department of DermatologyHenry Ford HospitalDetroitUSA
  3. 3.Icecreamwala DermatologyBerkeleyUSA

Personalised recommendations